LOS ANGELES, May 8, 2012 /PRNewswire/ -- Roger and Ann Worthington, longtime supporters of mesothelioma patients and their families, generously donated $25,000 to The Pacific Meso Center (PMC). "Their donation honors the mesothelioma patients and their families who joined other cancer survivors in the Amgen Breakaway from Cancer Walk at the Dana Point Grand Prix of Cycling on Sunday, May 6th 2012," said Clare Cameron, executive director of PMC. The walk took place at 3:35 p.m. prior to the professional men's race. The event on Sunday was the 6th annual Dana Point Grand Prix (DPGP), which is recognized as one of America's premier one-day professional races and has quickly gained accolades among athletes and sports fans as the best venue on the West Coast. The Breakaway from Cancer walk was founded in 2005 by Amgen as a national initiative to increase awareness of important resources available to people affected by cancer - from prevention through survivorship. The walk this year was led by the drum line from Dana Hills High School. Hundreds of walkers joined hands and strode in solidarity on the most beautiful race course in America, celebrating life and soaking up the California sunshine. Mesothelioma survivor Terry Latham of Dana Point was delighted to be part of the walk once again. He stated that he was thankful to his surgeon Dr. Robert B. Cameron, scientific advisor at PMC, who has extended his life. "Every day is a gift and I'm happy to be alive to walk this course with other survivors," Terry said. "This event is about hope," he added. "On a day bursting with wonder and light, from the kids races to the professional races," beamed Roger Worthington, a mesothelioma lawyer who also is the President of the Dana Point Community Cycling Foundation, Inc., a 501(c)(3) non-profit, "it was particularly gratifying to see so many mesothelioma patients and their families get their moment in the sun." About The Pacific Meso Center: The Pacific Meso Center (PMC) is a division of the Pacific Heart, Lung & Blood Institute, a 501(c)(3) non-profit medical research institute established in 2002 which is focused on the treatment and prevention of malignant pleural mesothelioma (MPM). The exploration of innovative ideas forms the foundation of PMC's unique research program and provides the promise of future treatment breakthroughs. PMC is dedicated to educating the public on asbestos-related diseases and informing them of their best treatment options. PMC also connects newly diagnosed patients with patients that have been through treatment and provides assistance and emotional support.